CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Avar-e

SODIUM SULFACETAMIDE 10% AND SULFUR 5% Emollient Cream· ingredient sulfacetamidePreparations containing sulfur· SULFACETAMIDE SODIUM 100 mg/g; SULFUR 50 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.68695
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other sulfacetamide products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
Sodium Sulfacetamide 8% and Sulfur 4%$0.06467−$0.62230
Sodium Sulfacetamide 9% and Sulfur 4.5% Cleanser$0.07818−$0.60880
OVACE$0.11417−$0.57280
Plexion$0.12999−$0.55700
AVAR$0.17118−$0.51580
Sodium Sulfacetamide 9% and Sulfur 4% Cleanser$0.36031−$0.32660
Klaron$0.53594−$0.15100
sulfacetamide sodium$1.86+$1.18

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.